1-3 of 3
Xiangjun Fu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Hetrombopag Added to Immunosuppressive Therapy in First-Line Treatment of Severe Aplastic Anemia: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial

Fengkui Zhang, Xin Zhao, Hong Chang, Bing Han, Sujun Gao, Miao Miao, Jianda Hu, Yanjuan Lin, Xinjian Liu, Lina Zhang, Chenghao Jin, Yingmei Li, Shengyun Lin, Jinsong Jia, Yi Wang, Chunkang Chang, Zheng Ge, Guangsheng He, Ruixiang Xia, Xiangjun Fu, Yuhua Li, Hong Liu, Kai Sun, Shunqing Wang, Linghui Xia, Weihua Zhang, Runzi Li, Junye Xiong, Wanyi Zhai
Journal: Blood
Blood (2024) 144 (Supplement 1): 304.
https://doi.org/10.1182/blood-2024-206377
Published: 2024
Journal Articles

Rituximab, Chidamide, and Zanubrutinib±CHOP Could be a Promising Regimen for Newly Diagnosed Double-Expressor DLBCL (DE DLBCL)

Zhiming Li, Peng Sun, Lu Zhang, Xiangjun Fu, Yirong Jiang, Zhi Guo, Panpan LIU, Yu Wang, Hang Yang, Kangming Huang
Journal: Blood
Blood (2024) 144 (Supplement 1): 7807.
https://doi.org/10.1182/blood-2024-202818
Published: 2024
Journal Articles

Update Results of a Phase II Trial of Venetoclax in Combination with Azacitidine and Chidamide in Relapsed/Refractory Acute Myeloid Leukemia

Jie Zha, Ying Wang, Zhenling Li, Zhijuan Lin, Yun Cai, Tiejun Gong, Wei Yang, Siting Xie, Zhenqi Huang, Pengcheng SHI, Lin Fu, Jinghua Wang, Xiangjun Fu, Xianqi Feng, Liping Su, Jianmin Luo, Lin Yang, Biyun Chen, Ying Xie, Yu Zhu, Xin Du, Yirong Jiang, Zhifeng Li, Bing Xu
Journal: Blood
Blood (2023) 142 (Supplement 1): 4274.
https://doi.org/10.1182/blood-2023-182832
Published: 2023